Adiponectin, a unique adipocyte-derived factor beyond hormones. (January 2020)

• Record Type: Journal Article
• Authors: Maeda, Norikazu; Funahashi, Tohru; Matsuzawa, Yuji; Shimomura, Iichiro
• Is Part Of: Atherosclerosis. Volume 292(2020)
• Page Start: 1
• Page End: 9
• Publication Date: 2020-01
• Subjects: Adiponectin -- Metabolic syndrome -- Atherosclerosis -- Exosome -- T-cadherin; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2019.10.021
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Visceral fat accumulation has a marked impact on atherosclerotic cardiovascular diseases and metabolic syndrome clustering diabetes, dyslipidemia, and hypertension. Adiponectin, an adipocyte-derived circulating protein, is a representative adipocytokine and uniquely possesses two major properties: 1) its circulating concentration is approximately 3–6 orders of magnitude greater than ordinary hormones and cytokines; 2) its concentration inversely correlates with body fat mass despite its adipocyte-specific production. Low serum levels of adiponectin correlate with cardiometabolic diseases. Extensive experimental evidence has demonstrated that adiponectin possesses multiple properties, such as anti-atherosclerotic, anti-diabetic, and anti-inflammatory activities. It has been shown to play a central role against the development of metabolic syndrome and its complications. However, even approximately 25 years after its discovery, the properties of adiponectin, including how and why it exerts multiple beneficial effects on various tissues and/or organs, remain unclear. Furthermore, the mechanisms responsible for the very high circulating concentrations of adiponectin in the bloodstream have not been elucidated. Several adiponectin-binding partners, such as AdipoR1/2, have been identified, but do not fully explain the multi-functional and beneficial properties of adiponectin. Recent advances in adiponectin research may resolve these issues. Adiponectin binds to and covers cell surfaces with T-cadherin, a unique glycosylphosphatidylinositol (GPI)-anchored cadherin. The adiponectin/T-cadherin complex enhances exosomal production and release, excreting cell-toxic products from cells, particularly in the vasculature. In this review, we discuss adiponectin and the role of the adiponectin/T-cadherin system in the maintenance of whole body homeostasis and cardiovascular protection. Highlights: Adiponectin acts as a central player to prevent and protect from metabolic syndrome. Adiponectin enhances exosome biogenesis through T-cadherin. Adiponectin/T-cadherin system plays a crucial role in cardiovascular protection.